Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
SMO Clinplus CoSZSE:301257 -4.95%91 Dividend Yield % is 0.42% as of Sep. 12, 2026, which is 2% below its 10-year median of 0.43. GuruFocus rates SZSE:301257 with a GF Score™ of 91/100 and a GF Value™ of ¥38.90 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 60 Medical Diagnostics & Research companies, SMO Clinplus Co ranks worse than 85% on this metric.
As of today (2026-09-12), the Trailing Annual Dividend Yield of SMO Clinplus Co is 0.42%.
The historical rank and industry rank for SMO Clinplus Co's Dividend Yield % or its related term are showing as below:
SZSE:301257'
s Dividend Yield % Range Over the Past 10 Years
Min: 0.12 Med: 0.43 Max: 1.12
Current: 0.42
During the past 12 years, the highest Dividend Yield of SMO Clinplus Co was 1.12%. The lowest was 0.12%. And the median was 0.43%.
SZSE:301257's Dividend Yield % is ranked worse than 85% of 60
companies
in the Medical Diagnostics & Research industry
Industry Median: 2.23
vs SZSE:301257: 0.42
SMO Clinplus Co (SZSE:301257) Dividend Yield % Explanation
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
The historical data trend for SMO Clinplus Co's Dividend Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SZSE:301257 vs TMO, DHR, NTRA: Dividend Yield % Comparison
For the Diagnostics & Research subindustry, SMO Clinplus Co's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
SMO Clinplus Co Dividend Yield % vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, SMO Clinplus Co's Dividend Yield % distribution charts can be found below:
* The bar in red indicates where SMO Clinplus Co's Dividend Yield % falls into.
Dividend Yield measures how much a company pays out in dividends each year relative to its share price.
SMO Clinplus Co Recent Full-Year* Dividend History
Amount
Ex-date
Record Date
Pay Date
Type
Frequency
Forex Rate
CNY 0.080000
2026-07-09
2026-07-08
2026-07-09
Cash Dividend
quarterly
CNY:CNY 1.000000
CNY 0.068000
2025-11-28
2025-11-27
2025-11-28
Cash Dividend
semi-annually
CNY:CNY 1.000000
* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.
SMO Clinplus Co's Trailing Annual Dividend Yield (%) for Today is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SMO Clinplus Co (SZSE:301257) has a Dividend Yield % of 0.42% as of Sep. 12, 2026. Dividend yield is the ratio of company dividends to the share price. View historical data on SMO Clinplus Co and its competitors. This is near median its historical median of 0.43. Over the past decade, SMO Clinplus Co's Dividend Yield % has ranged from 0.12 to 1.12. According to the industry distribution chart, SMO Clinplus Co ranks #51 out of 60 companies in the Medical Diagnostics & Research industry, placing it in the top 85%.
Is SMO Clinplus Co's Dividend Yield % too high?
SMO Clinplus Co's current Dividend Yield % of 0.42% is near median its 10-year median of 0.43. Over the past 10 years, this metric has ranged from a low of 0.12 to a high of 1.12. The Medical Diagnostics & Research industry median Dividend Yield % is 2.23. SMO Clinplus Co's value of 0.42% is 81.2% below this industry median. Based on the distribution chart, SMO Clinplus Co ranks #51 out of 60 companies in the Medical Diagnostics & Research industry, which is in the bottom quartile relative to peers. Overall, SMO Clinplus Co has a GF Score™ of 91/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does SMO Clinplus Co's Dividend Yield % compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, SMO Clinplus Co ranks #51 out of 60 companies for Dividend Yield %. This places SMO Clinplus Co in the lower half of its industry. The industry median Dividend Yield % is 2.23. SMO Clinplus Co's value of 0.42% is 81.2% below this benchmark. Historically, SMO Clinplus Co's own Dividend Yield % has ranged from 0.12 to 1.12 over the past decade. While the company's 10-year median is 0.43 vs. the industry median of 2.23, SMO Clinplus Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Yield % for a Medical Diagnostics & Research company?
The median Dividend Yield % among Medical Diagnostics & Research companies is 2.23, based on 60 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. SMO Clinplus Co's current Dividend Yield % of 0.42% is 81.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Yield % mean?
A high Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Dividend yield is the ratio of company dividends to the share price. View historical data on SMO Clinplus Co and its competitors. For the Medical Diagnostics & Research industry, the median Dividend Yield % is 2.23 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. SMO Clinplus Co's current Dividend Yield % is 0.42%, which is near median its own 10-year median of 0.43. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SMO Clinplus Co stock overvalued right now?
Based on GuruFocus' analysis, SMO Clinplus Co (SZSE:301257) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥38.90, compared to a current price of ¥35.17 — trading 9.6% below its estimated fair value. The current Dividend Yield % is 0.42%, which is near median its 10-year median of 0.43 and 81.2% below the Medical Diagnostics & Research industry median of 2.23. SMO Clinplus Co's overall GF Score™ is 91/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Yield % calculated?
Dividend Yield % is calculated from a company's financial statements. For SMO Clinplus Co (SZSE:301257), the current Dividend Yield % is 0.42% as of Sep. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is SMO Clinplus Co (SZSE:301257) Overvalued in 2026?
Based on GuruFocus' analysis, SMO Clinplus Co stock appears to be undervalued.
The current stock price of ¥35.17 is trading 9.6% below its estimated GF Value™ of ¥38.90.
GuruFocus considers SMO Clinplus Co to be Modestly Undervalued.
Key valuation signals for SZSE:301257:
Dividend Yield %: 0.42% (near median its 10-year median of 0.43)
GF Value™: ¥38.90 vs. price of ¥35.17 (9.6% below fair value)
Industry Position: 81.2% below the Medical Diagnostics & Research median (#51 of 60)
No single metric tells the full story. See the SZSE:301257 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
SMO Clinplus Co Ltd is engaged in providing SMO services to domestic and foreign pharmaceutical companies, medical device companies, and clinical research and development of some health-related products. The services provided include Preliminary model establishment, Preliminary plan preparation, Initiation of clinical trial sites, On-site implementation, and Comprehensive project management.
91GF Score
Get the complete analysis for SZSE:301257
Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SZSE:301257 has been successfully added to your 
